Pain Management Overview

Principles

Definition

Pain management is a multidisciplinary academic and clinical field focused on the systematic assessment, diagnosis, treatment, and prevention of pain across various etiologies and presentations. This domain investigates physiological, psychological, and pharmacological interventions, alongside rehabilitative and procedural approaches, to optimize patient function and quality of life while minimizing suffering.

Ontological type

Core Interventions

Pharmacologic Strategies

Interventional Techniques

Key developments

Key Figures

Physiology and Neuromodulation era

Ronald Melzack [1] was associated with institutions such as the Massachusetts Institute of Technology [3] and the University of Washington [4] during this era. Melzack [1] advanced objective pain measurement and neuromodulation, as reflected in The Perception of Pain [8], The McGill Pain Questionnaire: Major properties and scoring methods [7], and Analgesia produced by brain stimulation: Evidence of a prolonged onset period [9], which established reproducible metrics and spurred neuromodulatory therapies in this era. H L Frankel [2] was affiliated with the University of California, San Francisco [5] and the University of Oxford [6] during this era. Frankel [2] contributed to pain management through postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia [10], a finding that helped shape nonpharmacologic analgesia and rehabilitation within interdisciplinary care.

Central Neurobiology of Pain era

Makoto Tominaga [1] emerges as a central figure in the Central Neurobiology of Pain era, with affiliations at University of California, San Francisco [3] and University of California, Berkeley [4] during this period. His key contribution this era is the 1997 paper, The capsaicin receptor: a heat-activated ion channel in the pain pathway [6], which identified the capsaicin receptor as a heat-activated ion channel in nociception and provided a molecular foothold for understanding pain signaling and analgesic development. Jon D. Levine [2] is also a leading figure, with affiliations at University of California, San Francisco [3] and Johns Hopkins University [5] during this era. His involvement in the capsaicin receptor study [6] helped establish that heat-activated nociceptor channels underpin peripheral pain signaling and that molecular discoveries from this era could advance translational analgesic strategies.

Translation to Clinical Care era

Philip J. Mease [1] is a leading figure in translating mechanistic pain science into clinical care during 2010-2023, with affiliations at Harvard University [3] and Stanford University [4]. Mease [1] co-led the 2010 paper The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity [5], which established a standardized, phenotype-based approach to fibromyalgia diagnosis and symptom assessment that enabled translational clinical care. Daniel J. Clauw [2] is a leading researcher affiliated with Harvard University [3] and Stanford University [4] contributing to mechanistic pain translation into clinical care in this era. Clauw [2] co-authored the same 2010 fibromyalgia criteria paper The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity [5], providing mechanistic context for phenotype stratification and enabling cross-disciplinary translation of research into care.